Article
Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer-A Nation-Wide Study.
International journal of molecular sciences - 22 May 2023
Potocki Paweł M, Wójcik Piotr, Chmura Łukasz, Goc Bartłomiej, Fedewicz Marcin, Bielańska Zofia, Swadźba Jakub, Konopka Kamil, Kwinta Łukasz, Wysocki Piotr J
Abstract excerpt
BRAF V600E and KRAS mutations that occur in colorectal cancer (CRC) define a subpopulation of patients with an inferior prognosis. Recently, the first BRAF V600E-targeting therapy has been approved and novel agents targeting KRAS G12C are being evaluated in CRC. A better understanding of the clinical characteristics of the populations defined by those mutations is needed. We created a retrospective database that...
Topics
- Humans
- Female
- Proto-Oncogene Proteins B-raf
- Proto-Oncogene Proteins p21(ras)
- Retrospective Studies
- Colorectal Neoplasms
- Mutation
- Brain Neoplasms
